SEARCH

SEARCH BY CITATION

References

  • Abebe G, Paasch F, Apers L et al. (2011) Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. Journal of Microbiological Methods 84, 155160.
  • Alangaden GJ, Kreiswirth BN, Aouad A et al. (1998) Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 42, 12951297.
  • Almeida Da Silva PE & Palomino JC (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. Journal of Antimicrobial Chemotherapy 66, 14171430.
  • Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A & Stakenas P (2003) Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrobial Agents and Chemotherapy 47, 20092011.
  • Banerjee A, Dubnau E, Quemard A et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227230.
  • Campbell PJ, Morlock GP, Sikes RD et al. (2011) Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 55, 20322041.
  • Chen Q, Pang Y, Liang Q et al. (2014). Molecular characteristics of MDR Mycobacterium tuberculosis strains isolated in Fujian, China. Tuberculosis 94, 159161.
  • Cheng S, Cui Z, Li Y & Hu Z. (2014) Diagnostic accuracy of a molecular drug susceptibility testing method for the TB drug, ethambutol: a systematic review and meta-analysis. Journal of Clinical Microbiology doi: 10.1128.
  • Falzon D, Jaramillo E, Schunemann HJ et al. (2011) WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. European Respiratory Journal 38, 516528.
  • Guo JH, Xiang WL, Zhao QR et al. (2008) Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Sichuan Province in China. Japanese Journal of Infectious Diseases 61, 264268.
  • Iwamoto T, Yoshida S, Suzuki K & Wada T (2008) Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrobial Agents and Chemotherapy 52, 38053809.
  • Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F & Rigouts L (2009) High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrobial Agents and Chemotherapy 53, 50645068.
  • Lee AS, Lim IH, Tang LL, Telenti A & Wong SY (1999) Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrobial Agents and Chemotherapy 43, 20872089.
  • Luo T, Zhao M, Li X et al. (2010) Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. Antimicrobial Agents and Chemotherapy 54, 10751081.
  • Madison B, Robinson-Dunn B, George I et al. (2002) Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. Journal of Clinical Microbiology 40, 39763979.
  • Mallik I, Arabiat S, Pasche J, Bolton MD, Patel JS & Gudmestad NC (2014) Molecular characterization and detection of mutations associated with resistance to succinate dehydrogenase inhibiting (SDHI) fungicides in Alternaria solani. Phytopathology 104, 4049.
  • Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L & Vyshnevskiy B (2002) High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia 1996 to 2001. Antimicrobial Agents and Chemotherapy 46, 14171424.
  • Pang Y, Zhou Y, Wang S et al. (2011) A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of Mycobacterium tuberculosis. Journal of Microbiological Methods 86, 291297.
  • Pang Y, Zhou Y, Zhao B et al. (2012) Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS ONE 7, e32976.
  • Pang Y, Xia H, Zhang Z et al. (2013) Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. Journal of Clinical Microbiology 51, 17071713.
  • Parsons LM, Somoskövi Á, Gutierrez C et al. (2011) Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clinical Microbiology Reviews 24, 314350.
  • Plinke C, Rusch-Gerdes S & Niemann S (2006) Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy 50, 19001902.
  • Plinke C, Cox HS, Kalon S et al. (2009) Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results. Tuberculosis 89, 448452.
  • Poudel A, Nakajima C, Fukushima Y et al. (2012) Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal. Antimicrobial Agents and Chemotherapy 56, 28312836.
  • Ramaswamy S & Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and Lung Disease 79, 329.
  • van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H & Borgdorff MW (2000) Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. Journal of Infectious Diseases 182, 17881790.
  • World Health Organization. (2008) TB Drug Resistance in The World. In Report no. 4. WHO/HTM/TB/2008.394. World Health Organization, Geneva, Switzerland.
  • World Health Organization. (2013a) Global Tuberculosis Report 2013. WHO/HTM/TB/2013.11. World Health Organization, Geneva, Switzerland.
  • World Health Organization. (2013b) The Use of Molecular Line Probe Assay for The Detection of Resistance to Second-line TB Drugs. WHO/HTM/TB/2013.01. World Health Organization, Geneva, Switzerland.
  • Yuan X, Zhang T, Kawakami K et al. (2012) Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. Journal of Clinical Microbiology 50, 24042413.
  • Yue J, Shi W, Xie J, Li Y, Zeng E & Wang H (2003) Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. Journal of Clinical Microbiology 41, 22092212.
  • Zhang Y, Heym B, Allen B, Young D & Cole S (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591593.
  • Zhang D, An J, Wang J et al. (2013) Molecular typing and drug susceptibility of Mycobacterium tuberculosis isolates from Chongqing Municipality, China. Infection, Genetics and Evolution 13, 310316.
  • Zhang Z, Lu J, Wang Y, Pang Y & Zhao Y (2014a) Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China. Antimicrobial Agents and Chemotherapy 58, 364369.
  • Zhang Z, Wang Y, Pang Y & Kam KM (2014b) Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 52, 638641.
  • Zhao Y, Xu S, Wang L et al. (2012) National survey of drug-resistant tuberculosis in China. New England Journal of Medicine 366, 21612170.